Contact Us

PLx Pharma is located in Houston near the Texas Medical Center.

PLx Pharma Inc.
8285 El Rio, Suite 130
Houston, TX 77054
Tel: 713-842-1249
Fax: 713-842-3052

PLx Pharma News

Press Releases

Aug. 9, 2011: PLx Pharma Appoints Industry Leader Michael J. Valentino as Chairman of the Board
   

Jun. 30, 2011: Cambrex and Tillotts Enter a Development and Commercialization Agreement for 5-ASA-Based Technology
   

Nov. 16, 2010: PLx Pharma's PL2200 Phase 2 Trial Results Showing Significant Decrease in the Risk of Ulcers vs Aspirin Published in American Journal of Gastroenterology
   

May 12, 2010: PLx Pharma Receives of Multiple Grants from the National Institutes of Health
   

April 28, 2010: PLx Pharma's PL2200 Aspirin Demonstrates Significant Decrease in the Risk of Ulcers and Erosions Compared to Immediate Release Aspirin in Phase 2 Trial
   

June 16, 2008: PLx Pharma Demonstrates Bioequivalence with aspirin and PL2100 ~ Aspirin-PC
   

September 11, 2007: Barry J. Marshall, MD joins the Scientific Advisory Board
   

April 6, 2007: PLx Pharma Secures over $7,500,000 in Funding to Support NSAID-PC Product Development

November 1, 2006: Kim Rainsford, Ph.D. joins the Scientific Advisory Board
    

October 30, 2006: Brendan Whittle, Ph.D. joins the Scientific Advisory Board
   

July 12, 2006: Haile T. Debas, MD, joins the Scientific Advisory Board
   

Other PLx Press

UT-Houston Spin-Off Company Crafts Better Aspirin, Ibuprofen